Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: An 11-year single-center experience

Liver Transplantation

Volumn 17, Issue 8, 2011, Pages 976-984

  Nafady Hego, Hanaa ^a,b   Elgendy, Hamed ^a,b   Moghazy, Walid El ^a,c   Fukuda, Kazuhiko ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Assiut University Faculty of Medicine   (Egypt)

^c SOHAG UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASCITES; BACTERIAL INFECTION; BILE LEAKAGE; CANDIDA; CAUSE OF DEATH; CHILD; ENTEROCOCCUS; FEMALE; FUNGUS ISOLATION; HUMAN; INCIDENCE; INFECTION RATE; INTRAVASCULAR CATHETER; JAPAN; LENGTH OF STAY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MYCOSIS; NONHUMAN; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL INFECTION;

ADOLESCENT; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CANDIDA; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENGTH OF STAY; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MYCOSES; POSTOPERATIVE COMPLICATIONS; PSEUDOMONAS AERUGINOSA; RISK FACTORS; STAPHYLOCOCCUS AUREUS;

EID: 79960830773     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22278     Document Type: Article

References (35)

1. Rosenthal P, Podesta L, Sher L, Makowka L,. Liver transplantation in children. Am J Gastroenterol 1994; 89: 480-492. (Pubitemid 24106210)
2. Tanaka K,. Progress and future in living donor liver transplantation. Keio J Med 2003; 52: 73-79. (Pubitemid 36834400)
3. Fridell JA, Jain A, Reyes J, Biederman R, Green M, Sindhi R, Mazariegos GV,. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation 2002; 74: 1721-1724. (Pubitemid 36019326)
4. Jain A, Mazariegos G, Kashyap R, Kosmach-Park B, Starzl TE, Fung JJ, Reyes J,. Pediatric liver transplantation in 808 consecutive children: 20-years experience from a single center. Transplant Proc 2002; 34: 1955-1957.
5. Aydogdu S, Arikan C, Kilic M, Ozgenc F, Akman S, Unal F, et al. Outcome of pediatric liver transplant recipients in Turkey: single center experience. Pediatr Transplant 2005; 9: 723-728. (Pubitemid 41680706)
6. Shepherd RW, Turmelle Y, Nadler M, Lowell JA, Narkewicz MR, McDiarmid SV, et al.; SPLIT Research Group. Risk factors for rejection and infection in pediatric liver transplantation. Am J Transplant 2008; 8: 396-403.
7. Kim JE, Oh SH, Kim KM, Choi BH, Kim DY, Cho HR, et al. Infections after living donor liver transplantation in children. J Korean Med Sci 2010; 25: 527-531.
8. Uemoto S, Tanaka K, Fujita S, Sano K, Shirahase I, Kato H, et al. Infectious complications in living related liver transplantation. J Pediatr Surg 1994; 29: 514-517. (Pubitemid 24132656)
9. Tanaka K, Uemoto S, Tokunaga Y, Fujita S, Sano K, Nishizawa T, et al. Surgical techniques and innovations in living related liver transplantation. Ann Surg 1993; 217: 82-91. (Pubitemid 23033223)
10. Inomata Y, Tanaka K, Egawa H, Uemoto S, Ozaki N, Okajima H, et al. The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. Transplantation 1996; 61: 247-252. (Pubitemid 26044539)
11. Demetris AJ, Qian SG, Sun H, Fung JJ,. Liver allograft rejection: an overview of morphologic findings. Am J Surg Pathol 1990; 14 (Suppl 1): 49-63. (Pubitemid 20077635)
12. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25: 658-663.
13. Tokunaga Y, Tanaka K, Fujita S, Yamaguchi T, Sawada H, Kato H, et al. Living related liver transplantation across ABO blood groups with FK506 and OKT3. Transpl Int 1993; 6: 313-318. (Pubitemid 23325250)
14. Egawa H, Oike F, Buhler L, Shapiro AM, Minamiguchi S, Haga H, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77: 403-411. (Pubitemid 38209740)
15. Warren NG, Hazen KC,. 1999. Candida, Cryptococcus, and other yeasts of medical importance. In:, Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press. p 1184-1199.
16. Takakura S, Fujihara N, Saito T, Kimoto T, Ito Y, Iinuma Y, Ichiyama S,. Improved clinical outcome of patients with Candida bloodstream infections through direct consultation by infectious diseases physicians in a Japanese university hospital. Infect Control Hosp Epidemiol 2006; 27: 964-968. (Pubitemid 44449257)
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM,. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140.
18. Horan TC, Andrus M, Dudeck MA,. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332. (Pubitemid 351763841)
19. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
20. Iinuma Y, Senda K, Fujihara N, Saito T, Takakura S, Kudo T, et al. Surgical site infection in living-donor liver transplant recipients: a prospective study. Transplantation 2004; 78: 704-709. (Pubitemid 39244732)
21. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, et al.; Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14. (Pubitemid 33152659)
22. Saint-Vil D, Luks FI, Lebel P, Brandt ML, Paradis K, Weber A, et al. Infectious complications of pediatric liver transplantation. J Pediatr Surg 1991; 26: 908-913.
23. Araz C, Pirat A, Torgay A, Zeyneloglu P, Arslan G,. Early postoperative complications of pediatric liver transplantation: experience at one center. Transplant Proc 2004; 36: 214-217. (Pubitemid 38177237)
24. García S, Roque J, Ruza F, González M, Madero R, Alvarado F, Herruzo R,. Infection and associated risk factors in the immediate postoperative period of pediatric liver transplantation: a study of 176 transplants. Clin Transplant 1998; 12: 190-197. (Pubitemid 28269240)
25. George DL, Arnow PM, Fox A, Thistlethwaite JR, Emond JC, Broelsch CE, Whitington PF,. Patterns of infection after pediatric liver transplantation. Am J Dis Child 1992; 146: 924-929.
26. Egawa H, Inomata Y, Uemoto S, Asonuma K, Kiuchi T, Fujita S, et al. Biliary anastomotic complications in 400 living related liver transplantations. World J Surg 2001; 25: 1300-1307. (Pubitemid 32952579)
27. Bouchut JC, Stamm D, Boillot O, Lepape A, Floret D,. Postoperative infectious complications in paediatric liver transplantation: a study of 48 transplants. Paediatr Anaesth 2001; 11: 93-98. (Pubitemid 32055851)
28. Nagao M, Iinuma Y, Saito T, Matsumura Y, Shirano M, Matsushima A, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010; 16: 1783-1788.
29. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. American Society of Health-System Pharmacists. Am J Health Syst Pharm 1999; 56: 1839-1888.
30. Asensio A, Ramos A, Cuervas-Mons V, Cordero E, Sánchez- Turriõn V, Blanes M, et al.; Red de Estudio de la Infecciõn en el Trasplante-Grupo de Estudio de la Infecciõn en el Trasplante. Effect of antibiotic prophylaxis on the risk of surgical site infection in orthotopic liver transplant. Liver Transpl 2008; 14: 799-805. (Pubitemid 351895509)
31. Wagener MM, Yu VL,. Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 1992; 20: 239-247.
32. Singh N, Squier C, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV,. Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients. Infect Control Hosp Epidemiol 2006; 27: 122-126. (Pubitemid 43384757)
33. Fortún J, Martín-Davila P, Moreno S, Barcena R, de Vicente E, Honrubia A, et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003; 52: 813-819. (Pubitemid 37407810)
34. Gladdy RA, Richardson SE, Davies HD, Superina RA,. Candida infection in pediatric liver transplant recipients. Liver Transpl Surg 1999; 5: 16-24. (Pubitemid 29037349)
35. Cakir M, Arikan C, Akman SA, Baran M, Saz UE, Yagci RV, et al. Infectious complications in pediatric liver transplantation candidates. Pediatr Transplant 2010; 14: 82-86.